Closing the Treatment Gap: Opioid Use Disorder Medications in Adolescents and Young Adults
Closing the Treatment Gap: Opioid Use Disorder Medications in Adolescents and Young Adults https://pediatricsnationwide.org/wp-content/uploads/2019/05/AdobeStock_69121448-1024x683.jpg 1024 683 Pam Georgiana https://pediatricsnationwide.org/wp-content/uploads/2023/07/May-2023.jpgFindings from the PROUD trial highlight the need for youth-centered prescription strategies in primary care. Adolescents and young adults are far less likely than older adults to receive evidence-based medications for opioid use disorder (OUD), even though buprenorphine and extended-release naltrexone are recommended treatments. Despite their effectiveness, these therapies remain consistently underutilized in youth. To…




